Danaher Acquires Aldevron for $9.6 Billion

June 17, 2021

Danaher Corporation entered into a definitive agreement to acquire Aldevron from EQT Private Equity for an enterprise value of approximately USD 9.6 billion. Aldevron, headquartered in Fargo, North Dakota with ~600 employees and additional operations in Madison, Wisconsin, will operate as a standalone company within Danaher's Life Sciences segment to expand Danaher's capabilities in genomic medicine and biologics manufacturing.

Targets
Aldevron
Sellers
EQT Private Equity (EQT VIII) and selling shareholders
Industry
Biotechnology
Location
North Dakota, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.